BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36233156)

  • 1. The Effect of Aflatoxin B1 on Tumor-Related Genes and Phenotypic Characters of MCF7 and MCF10A Cells.
    Adam MAA; Kamal LZM; Kanakal M; Babu D; Dahham SS; Tabana Y; Lok B; Bermoy BM; Yunus MA; Than LTL; Barakat K; Sandai D
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations associated with in vivo aflatoxin B1-induced carcinogenesis need not be present in the in vitro transformations by this toxin.
    Stanley LA; Mandel HG; Riley J; Sinha S; Higginson FM; Judah DJ; Neal GE
    Cancer Lett; 1999 Apr; 137(2):173-81. PubMed ID: 10374839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines.
    Macé K; Aguilar F; Wang JS; Vautravers P; Gómez-Lechón M; Gonzalez FJ; Groopman J; Harris CC; Pfeifer AM
    Carcinogenesis; 1997 Jul; 18(7):1291-7. PubMed ID: 9230270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study on functional characters of MCF7 and HCC1937 cell lines in response to DNA damage].
    Dong C; Zhang F; Zhao X; Guo G; Luo Y; Feng Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Sep; 48(9):809-14. PubMed ID: 25492294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of aflatoxin B1 by mouse CYP2A enzymes and cytotoxicity in recombinant yeast cells.
    Pelkonen P; Lang MA; Wild CP; Negishi M; Juvonen RO
    Eur J Pharmacol; 1994 Nov; 292(1):67-73. PubMed ID: 7867691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of TFIIS by RNA silencing inhibits cancer cell proliferation and induces apoptosis.
    Hubbard K; Catalano J; Puri RK; Gnatt A
    BMC Cancer; 2008 May; 8():133. PubMed ID: 18474089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aflatoxin B1 Induces Neurotoxicity through Reactive Oxygen Species Generation, DNA Damage, Apoptosis, and S-Phase Cell Cycle Arrest.
    Huang B; Chen Q; Wang L; Gao X; Zhu W; Mu P; Deng Y
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary evidence that degradation of aflatoxin B1 by Flavobacterium aurantiacum is enzymatic.
    Smiley RD; Draughon FA
    J Food Prot; 2000 Mar; 63(3):415-8. PubMed ID: 10716576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of ebselen on aflatoxin B1-induced cytotoxicity in primary rat hepatocytes.
    Yang CF; Liu J; Shen HM; Ong CN
    Pharmacol Toxicol; 2000 Apr; 86(4):156-61. PubMed ID: 10815748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference with mutagenic aflatoxin B1-induced checkpoints through antagonistic action of ochratoxin A in intestinal cancer cells: a molecular explanation on potential risk of crosstalk between carcinogens.
    Kim J; Park SH; Do KH; Kim D; Moon Y
    Oncotarget; 2016 Jun; 7(26):39627-39639. PubMed ID: 27119350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined low-dose zearalenone and aflatoxin B1 on cell growth and cell-cycle progression in breast cancer MCF-7 cells.
    Yip KY; Wan MLY; Wong AST; Korach KS; El-Nezami H
    Toxicol Lett; 2017 Nov; 281():139-151. PubMed ID: 28965971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
    Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
    Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of p53 and reactive oxygen species in apoptotic response to copper and zinc in epithelial breast cancer cells.
    Ostrakhovitch EA; Cherian MG
    Apoptosis; 2005 Jan; 10(1):111-21. PubMed ID: 15711927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aflatoxin B1 and polycyclic aromatic hydrocarbon adducts, p53 mutations and p16 methylation in liver tissue and plasma of hepatocellular carcinoma patients.
    Zhang YJ; Rossner P; Chen Y; Agrawal M; Wang Q; Wang L; Ahsan H; Yu MW; Lee PH; Santella RM
    Int J Cancer; 2006 Sep; 119(5):985-91. PubMed ID: 16570275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell viability and electrical response of breast cancer cell treated in aqueous graphene oxide solution deposition on interdigitated electrode.
    Ramli MM; Rosman AS; Mazlan NS; Ahmad MF; Halin DSC; Mohamed R; Osman NH; Reshak AH
    Sci Rep; 2021 Oct; 11(1):20702. PubMed ID: 34667216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation and mapping of aflatoxin B1-induced DNA damage in genomic DNA using aflatoxin B1-8,9-epoxide and microsomal activation systems.
    Denissenko MF; Cahill J; Koudriakova TB; Gerber N; Pfeifer GP
    Mutat Res; 1999 Apr; 425(2):205-11. PubMed ID: 10216213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-exposure to 50 Hz-electromagnetic fields enhanced the antiproliferative efficacy of 5-fluorouracil in breast cancer MCF-7 cells.
    Han Q; Chen R; Wang F; Chen S; Sun X; Guan X; Yang Y; Peng B; Pan X; Li J; Yi W; Li P; Zhang H; Feng D; Chen A; Li X; Li S; Yin Z
    PLoS One; 2018; 13(4):e0192888. PubMed ID: 29617363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA damage checkpoint response to aflatoxin B1.
    Engin AB; Engin A
    Environ Toxicol Pharmacol; 2019 Jan; 65():90-96. PubMed ID: 30594067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effects of arsenic disulfide on the viability, migratory ability, apoptosis and autophagy of breast cancer cells.
    Zhao Y; Onda K; Sugiyama K; Yuan B; Tanaka S; Takagi N; Hirano T
    Oncol Rep; 2019 Jan; 41(1):27-42. PubMed ID: 30320388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.